SCHEMBL10076626

SCHEMBL10076626

CC(=O)C1CCN2CCCNC(=O)N12

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 1/20 0.30
CDA P32320 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21547466 0.90 NPSR1 (0.33) L3MBTL1KMT2A
SCHEMBL12449420 0.87 ALDH1A1 (0.34) L3MBTL1KMT2A
SCHEMBL17050171 0.75 ALDH1A1 (0.33) L3MBTL1KMT2A
SCHEMBL18571360 0.74
SCHEMBL8280285 0.71 ACE (0.43)
SCHEMBL8278544 0.71
SCHEMBL24983126 0.70
SCHEMBL17037252 0.70
SCHEMBL8277265 0.69 L3MBTL1 (0.39) L3MBTL1KMT2A
SCHEMBL8280295 0.68 ACE (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2468744-A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-27 EP disclosed
EP-2311851-A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-20 EP disclosed